Ameri Holdings News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

25.11.24	Enveric's Pre-clinical Study Of EB-003 Shows Bioavailability, Brain Penetration In Animal Studies (RTTNews)
15.07.24	Aries Science Inks Licensing Deal For Enveric Biosciences' Radiation Dermatitis Topical Product (RTTNews)
29.02.24	Enveric Signs Term Sheets To Pursue Out-licensing Of Three Classes Of Compounds (RTTNews)
23.02.24	Enveric Biosciences To Sell Cannabinoid-Related Cancer Intellectual Property; Stock Up In Pre-Market (RTTNews)
29.08.23	Pre-market Movers: TIVC, NCNC, PDD, FLAG, VFS… (RTTNews)
17.07.23	Enveric Biosciences Reports Positive Results From Animal Studies With EB-373 (RTTNews)
19.05.23	Pre-market Movers: MGRM, SDA, FTCH, CWD, PHIO… (RTTNews)
15.05.23	Enveric Biosciences Plans About 35 Percent Reduction In Full-time Personnel (RTTNews)
10.10.22	Pre-market Movers: HRMY, MPTI, LUCY, NURO, ACMR… (RTTNews)
16.12.21	Pre-market Movers: CALT, SABS, IRNT, CTK, VALN… (RTTNews)
06.12.21	Enveric Biosciences Appoints Bob Dagher As Chief Medical Officer - Quick Facts (RTTNews)
10.11.21	Pre-market Movers: STRN, SOPA, PRPL, POSH, GPL… (RTTNews)
05.10.21	Enveric Biosciences Announces Artificial Intelligence Platform, PsyAI™, Has Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds (PR Newswire)
17.09.21	Enveric Biosciences Concludes Acquisition Of Privately Held MagicMed Industries (RTTNews)
18.08.21	Enveric Biosciences CEO, David Johnson, Issues Letter to Shareholders (PR Newswire)
08.07.21	Enveric Biosciences Announces Approval from Israel's Ministry of Health to Begin its Phase 1/2 Trial of Triple-Combination CBD Treatment for Glioblastoma (PR Newswire)
26.06.21	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Enveric Biosciences, Inc. - ENVB (PR Newswire)
24.05.21	Enveric To Buy Drug Discovery And Development Platform MagicMed In All Stock Deal (RTTNews)
12.04.21	Enveric Biosciences Names Carter Ward CFO - Quick Facts (RTTNews)
11.03.21	Enveric Biosciences Acquires License For Diverse Biotech Novel Molecules (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V